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a b s t r a c t
The vacuolated lens (vl) mouse mutation arose on the C3H/HeSnJ background and results in lethality,
neural tube defects (NTDs) and cataracts. The vl phenotypes are due to a deletion/frameshift mutation in
the orphan GPCR, Gpr161. A recent study using a null allele demonstrated that Gpr161 functions in
primary cilia and represses the Shh pathway. We show the hypomorphic Gpr161vl allele does not
severely affect the Shh pathway. To identify additional pathways regulated by Gpr161 during neurula-
tion, we took advantage of naturally occurring genetic variation in the mouse. Previously Gpr161vl-C3H
was crossed to different inbred backgrounds including MOLF/EiJ and the Gpr161vl mutant phenotypes
were rescued. Five modiﬁers were mapped (Modvl: Modiﬁer of vl) including Modvl5MOLF. In this study
we demonstrate the Modvl5MOLF congenic rescues the Gpr161vl-associated lethality and NTDs but not
cataracts. Bioinformatics determined the transcription factor, Cdx1, is the only annotated gene within the
Modvl5 95% CI co-expressed with Gpr161 during neurulation and not expressed in the eye. Using Cdx1 as
an entry point, we identiﬁed the retinoid acid (RA) and canonical Wnt pathways as downstream targets
of Gpr161. QRT-PCR, ISH and IHC determined that expression of RA and Wnt genes are down-regulated in
Gpr161vl/vl but rescued by the Modvl5MOLF congenic during neurulation. Intraperitoneal RA injection
restores expression of canonical Wnt markers and rescues Gpr161vl/vl NTDs. These results establish the
RA and canonical Wnt as pathways downstream of Gpr161 during neurulation, and suggest that
Modvl5MOLF bypasses the Gpr161vl mutation by restoring the activity of these pathways.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Vacuolated lens (vl) arose spontaneously on the C3H/HeSnJ
inbred background. Gpr161vl/vl C3H mice display NTDs with 100%
penetrance, with the NTDs being localized to the developing spinal
cord. The severity of NTDs varies considerably and includes spina
biﬁda, milder dorsal midline defects, as well as a twisted neural
tube and/or bent tail (Wilson and Wyatt, 1986). Classical experi-
ments by Wilson and Wyatt suggest that the Gpr161vl allele affects
the last step in neurulation – apposition and fusion of the neural
folds. Ultrastructural EM studies uncovered abnormal cytoplasmic
blebs extruding from the neural folds instead of the normal
lamellipodia (Wilson and Wyatt, 1988a, 1988b, 1989). In addition
whole embryo cultures did not identify any defects in the neural
plate elevation and bending while all the embryos displayed
abnormal neural fold apposition and fusion (Wilson and Wyatt,
1993). Spina biﬁda that is observed in Gpr161vl/vl embryos could
then be due to the neural folds splaying apart after they fail to
fuse. In addition to NTDs, a certain percentage of Gpr161vl/vl
mutants also die during embryogenesis of unknown causes.
Finally, 100% of the surviving adult Gpr161vl/vl mutants have
congenital cataract while o5% display a belly spot phenotype
(Dickie, 1967; Matteson et al., 2008).
We previously positional cloned the Gpr161vl locus and identi-
ﬁed a deletion/frameshift mutation in the orphan G-protein
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coupled receptor, Gpr161. Gpr161 is expressed widely in the
developing embryo including the neural folds and the developing
lens. The Gpr161vl allele is a hypomorphic mutation that truncates
the C-terminal intracellular domain of the receptor, leading to
reduced steady state protein level and a disruption of receptor
mediated endocytosis process, which is known to attenuate G-
protein signaling (Matteson et al., 2008).
Genetic variation between different inbred strains of mice has
been used to study the basis of many multi-genic disease relevant
phenotypes. These variations can also affect the penetrance and
severity of phenotypes associated with monogenic mouse
mutants. We found previously that the Gpr161vl mutant pheno-
types are rescued when crossed to the C57BL6/J, CAST/Ei and
MOLF/Ei genetic backgrounds. In our MOLF cross the lethality was
completely rescued, cataract was partially suppressed while a 40%
increase in the belly spot phenotype was observed. These data
suggested that unlinked modiﬁers could bypass the effect of the
Gpr161vl mutation. Subsequent Quantitative Trait Locus (QTL)
analysis mapped 5 modiﬁers: Modiﬁers of vacuolated lens –
Modvl1 through 5 (Korstanje et al., 2008; Matteson et al., 2008).
Modvl5 was mapped in our MOLF cross, and we decided to focus
on Modvl5 in this manuscript because it had the smallest 95%
conﬁdence interval (17 Mb on Chr 18) and the highest LOD score
(5.0) (Korstanje et al., 2008).
Gpr161 has recently been shown to localize and function in
primary cilia. Many primary ciliary mutants affect Shh signaling,
ventralize neural tube patterning and cause NTDs (Bay and Caspary,
2012; Goetz and Anderson, 2010). The Gpr161 null allele signiﬁ-
cantly upregulates the Shh signaling, resulting in severe craniofacial
defects, exencephaly and craniorachischisis (Mukhopadhyay et al.,
2013). These phenotypes are not observed in the Gpr161vl/vl and we
also show in this study that the Gpr161vl allele does not severely up-
regulate the Shh pathway.
The above results suggest that Gpr161 regulates other path-
ways during neurulation. To identify these pathways we have
taken advantage of naturally occurring genetic variation between
inbred mouse strains. We demonstrate that Modvl5MOLF rescues
the Gpr161vl-associated embryonic lethality and NTDs. The retinoic
acid (RA) and canonical Wnt pathways are down-regulated in
Gpr161vl/vl and rescued by Modvl5MOLF. RA injections are sufﬁcient
to rescue the Gpr161vl NTD phenotypes and up-regulate the
expression of canonical Wnt genes. These data indicate that the
RA and canonical Wnt pathways function downstream of the
Gpr161 during neurulation, providing new insight into the func-
tion of Gpr161.
Results
Modvl5MOLF rescues Gpr161vl-associated lethality
To test if the Modvl5MOLF is sufﬁcient to rescue the Gpr161vl-
associated lethality and NTD phenotypes, a Modvl5MOLF congenic
was generated by backcrossing C3H/MOLF hybrid mice to C3H
isogenic mice for 8–10 generations (see Material and Methods, and
Supplementary Fig. 1 for details). TheModvl5MOLF congenic has the
MOLF background for only the Modvl5 95% conﬁdence interval (CI)
which is 17 Mb on Chr 18 while the rest of the genome has the
C3H background including Gpr161vl mutation on Chr1.
Using a relatively limited number of mice, we previously
estimated that the incidence of Gpr161vl lethality on the isogenic
C3H background to be approximately 50%. To determine this more
precisely, we extended this analysis considerably by generating
over 600 adult mice from 3 different crosses (see Material and
Methods for details). If no lethality is observed, we estimated that
96 Gpr161vl/vl mice would be generated. Instead we observed 62
mutant mice, suggesting that the incidence of lethality was
approximately 36%.
Next, to test if Modvl5MOLF locus rescues Gpr161vl-associated
lethality, the Gpr161þ /vl Modvl5C/C x Gpr161þ /vl Modvl5C/M cross
was performed and 229 adult progeny were genotyped (Nomen-
clature: C/C¼C3H/C3H; C/M¼C3H/MOLF). Taking into account the
36% lethality for the Gpr161vl mutation, we expected to observe
8% of the total progeny to have a Gpr161vl/vl Modvl5C/C genotype.
14/229 or 6% were identiﬁed as Gpr161vl/vl Modvl5C/C which did not
signiﬁcantly deviate from the expected number (Chi-square test;
df¼1). However for Gpr161vl/vl Modvl5C/M mice, a signiﬁcant
deviation from 8% is detected with close to 12.5% (30/229) of the
adult mice having this genotype (Table 1 and Fig. 1). 12.5% is
expected if the Modvl5MOLF congenic completely rescues the
Gpr161vl-associated lethality. In addition, the number of wild type
and heterozygous mice did not deviate signiﬁcantly from the
expected percentages (Supplementary Table 1). The same analysis
was repeated for Gpr161þ /vl Modvl5C/M x Gpr161þ /vl Modvl5M/M
matings (M/M¼MOLF/MOLF) and similar rescue was again
observed for both Gpr161vl/vl Modvl5C/M and Gpr161vl/vl Modvl5M/
M adults (Supplementary Table 2). These results indicate that the
Modvl5MOLF congenic rescues the Gpr161vl-associated lethality in a
dominant manner.
To determine when during development the Gpr161vl mutation
causes the lethality and if the Modvl5MOLF congenic could rescue
the phenotype, the same matings were performed and embryos
were genotyped at E8.5, E9.5 and E11.5. The following number of
embryos was generated: E8.5 (291), E9.5 (111) and E11.5 (148). At
E8.5 the observed number of Gpr161vl/vl Modvl5C/C embryos is
signiﬁcantly higher than 8%, indicating that lethality has not yet
occurred. However at E9.5 and E11.5, the observed number of
Gpr161vl/vl Modvl5C/C embryos is similar to 8%, indicating the
occurrence of lethality. For Gpr161vl/vl Modvl5C/M embryos, signiﬁ-
cant deviation from 8% and rescue of lethality were observed at all
three developmental stages (Table 1 and Fig. 1, Supplementary
Table 1). These results demonstrate that Gpr161vl/vl Modvl5C/C
embryos die between E8.5 and E9.5, and the Modvl5MOLF congenic
is sufﬁcient to rescue the lethality.
Modvl5MOLF partially rescues Gpr161vl-associated NTDs
To test whether the Modvl5MOLF congenic rescues the Gpr161vl-
associated NTD phenotypes, Gpr161þ /vl Modvl5C/C x Gpr161þ /vl
Modvl5C/M matings were again performed and pregnant females
were sacriﬁced at E11.5. Given the variability of the Gpr161vl NTD
phenotypes, the neural tube phenotypes were divided into four
Table 1
Gpr161vl/vl lethality occurs between E8.5 and E9.5, and is rescued by theModvl5MOLF
congenic.
Age Genotypea Nb Expectedc Observed X2 P valued
E8.5 Gpr161vl/vl Modvl5C/C 291 23.28 33 4.06 0.00271
Gpr161vl/vl Modvl5C/M 23.28 34 4.94
E9.5 Gpr161vl/vl Modvl5C/C 111 8.88 9 0.001 0.01686
Gpr161vl/vl Modvl5C/M 8.88 16 5.71
E11.5 Gpr161vl/vl Modvl5C/C 148 11.84 14 2.51 0.00095
Gpr161vl/vl Modvl5C/M 11.84 23 11.94
Adult Gpr161vl/vl Modvl5C/C 229 18.32 14 1.02 0.00362
Gpr161vl/vl Modvl5C/M 18.32 30 7.45
a Gpr161þ /vl Modvl5C/C x Gpr161þ /vl Modvl5C/M mating was performed.
b The total number of progeny generated from the cross at each age.
c The expected number of Gpr161vl/vl progeny for each genotype. The expected
and observed number of progeny for the other genotypes is not shown for brevity
(see Supplementary Table 1). The percent lethality observed for Gpr161vl/vl mice is
estimated to be 36%.
d Chi-test was used to determine signiﬁcance (df¼1).
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groups: 1) normal neural tube, which shows a closed tubular
structure covered by surface ectoderm (Fig. 2A–C); 2) mild NTDs
which display a twisted neural tube and/or a bent tail (Fig. 2D–F);
3)moderate NTDs which include a widening of the dorsal midline
and ventricle that sometimes includes a central mass of inappro-
priately placed cells (Fig. 2G–I) and 4) severe NTDs that display an
open, everted neural plate resembling spina biﬁda (Fig. 2J–L).
For all the Gpr161þ /þ and Gpr161þ /vl embryos (N¼111), we
only observed a normal phenotype. On the contrary, all Gpr161vl/vl
Modvl5C/C embryos (N¼27) display mild, moderate or severe
NTDs, consistent with the 100% penetrance of the NTD phenotype
on the C3H background. Interestingly, the incidence of NTDs in
Gpr161vl/vl Modvl5C/M (N¼21) embryos is reduced with six
embryos (29%) exhibiting normal neural tubes that are indistin-
guishable to Gpr161þ /þ Modvl5C/C littermates (Fig. 2M). To deter-
mine if incidence of NTDs is signiﬁcantly decreased byModvl5MOLF,
embryos of each genotype were grouped into two categories: the
ones that display normal neural tube versus the ones that are
abnormal regardless of their NTD severities (mild, moderate or
severe). Fisher's exact test determined that Gpr161vl/vl Modvl5C/M
displays signiﬁcantly lower NTDs incidence than the Gpr161vl/vl
Modvl5C/C (po0.01) (Fig. 2N).
To determine if Modvl5MOLF congenic shifts the severity of the
NTD from severe to normal phenotypes, embryos were divided into
the four groups based on the phenotypes listed above (severe,
moderate, mild NTDs and normal). The Cochran-Mantel-Haenszel
test, which evaluates the statistical signiﬁcance of categorical data,
was then used to determine if the Modvl5MOLF congenic decreases
NTD severity. A signiﬁcant difference was observed between
Gpr161vl/vl Modvl5C/C and Gpr161vl/vl Modvl5C/M embryos (po0.05)
(Fig. 2N).
To investigate whether Modvl5MOLF homozygotes have addi-
tional effects on the NTD phenotypes, Gpr161þ /vl Modvl5C/M x
Gpr161þ /vl Modvl5M/M matings were performed. Gpr161vl/vl
Modvl5C/M and Gpr161vl/vl Modvl5M/M E11.5 littermates were com-
pared for the incidence and severity of NTDs using the same
methods mentioned above and no difference is observed (inci-
dence: p40.9999; severity: p¼0.6908). The Gpr161vl/vl Modvl5C/M
and Gpr161vl/vl Modvl5M/M littermates were also compared to
the Gpr161vl/vl Modvl5C/C progeny and a signiﬁcantly lower
NTD incidence and severity was observed (Fig. 2M and N). In
summary, these results indicate thatModvl5MOLF congenic partially
suppresses the incidence and severity of Gpr161vl-associated NTDs
in a dominant manner.
Modvl5MOLF does not rescue Gpr161vl-associated cataract
The same crosses were used to investigate whether the
Modvl5MOLF locus modiﬁes Gpr161vl-associated cataract. 495% of
adult Gpr161vl/vl Modvl5C/C, Gpr161vl/vl Modvl5C/M and Gpr161vl/vl
Modvl5M/M littermates display congenital cataract (Supplementary
Table 3), indicating that the Modvl5MOLF congenic does not rescue
the cataract defects. As intercrossing Gpr161vl-C3H to MOLF back-
ground partially rescued cataract, this result indicates that Mod-
vl5MOLF does not contribute to this effect.
Gpr161vl does not signiﬁcantly affect Shh signaling
Because Gpr161 functions in the primary cilia and primary cilia
mutants often cause NTDs by dysregulating the Shh pathway (Bay
and Caspary, 2012; Goetz and Anderson, 2010), we investigated the
effects of the Gpr161vl allele on Shh markers. In the Gpr161 null
allele that has recently been published (Mukhopadhyay et al., 2013),
qRTPCR demonstrates that Ptch1 mRNA level is increased by 4 fold,
and Gli1 mRNA level is increased by 3 fold in E8.5 embryos, while
Gli3 was decreased by 40%. However in E8.5 Gpr161vl/vl Modvl5C/C
mutants, Ptch1 was increased by only 60% and Gli1 was increased
by only 40%. For Gli3 instead of a 40% decrease in expression,
a 40% increase was observed in Gpr161vl/vl Modvl5C/C mutants
(Supplementary Fig. 2A). Because the NTD phenotypes are 100%
penetrant by E11.5, we also measured Ptch1, Gli1 and Gli3 levels at
this time point. No difference is observed between wild-type and
mutant embryos (Supplemental Fig. 2B). Finally we examined
whether the Modvl5MOLF congenic could rescue the minimal differ-
ence in expression of these genes at E8.5. No rescue of the Ptch1,
Gli1 or Gli3 expression was observed, indicating that any pheno-
typic suppression of the Gpr161vl phenotypes by the Modvl5MOLF
congenic is independent of the Shh pathway (Supplementary
Fig. 2A).
We then examined the spatial distribution of Gli1 and Gli3. Like
other primary cilia mutants that up-regulate the Shh pathway, the
Gpr161 null allele results in a signiﬁcant dorsal expansion of Gli1 in
both the neural plate and neural tube. In E8.5 Gpr161vl/vl mutants
the Gli1 ISHs does not demonstrate a similar signiﬁcant dorsal
Fig. 1. Gpr161vl-associated embryonic lethality occurs between E8.5 and E9.5 and is rescued by Modvl5MOLF congenic. The frequency of Gpr161vl/vl Modvl5C/C (black box) and
Gpr161vl/vl Modvl5C/M (white box) progeny at E8.5, E9.5, E11.5 and adult are shown. The top dashed line represents 12.5%, the expected frequency if no lethality is detected,
while the bottom dashed line represents 8%, the expected frequency if 36% lethality occurs. A chi-square test determined if the observed frequencies signiﬁcantly deviated
from 8%, which is denoted by an asterisk. At E8.5 both Gpr161vl/vl Modvl5C/C and Gpr161vl/vl Modvl5C/M embryos deviate from 8% indicating that lethality has not yet occurred.
At E9.5, E11.5 and adult Gpr161vl/vl Modvl5C/C genotypes do not differ from the expected 8% while Gpr161vl/vl Modvl5C/M genotypes deviate from the expected 8% and instead
are observed at 12.5%. These data indicate that lethality occurs between E8.5 and E9.5 and the Modvl5MOLF congenic completely rescues the lethality.
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expansion of expression in either the neural plate or neural tube.
In the Gpr161 null allele Gli3 expression was signiﬁcantly reduced
in the neural tube. For Gpr161vl/vl embryos no signiﬁcant difference
in Gli3 expression was observed in the neural plate or neural tube.
The Modvl5MOLF congenic also did not have signiﬁcant effects on
Gli1 and Gli3 expression (Supplementary Fig. 2C–H). These data
demonstrate that the Gpr161vl allele does not severely affect the
Shh pathway during neurulation and the Gpr161vl NTD pheno-
types are not due to an alteration of Shh signaling.
Gpr161vl does not affect ciliary localization
Gpr161 is localized to primary cilia in E16 neurons and ﬁve
amino acids in the IC3 domain are critical for the ciliary localiza-
tion (Mukhopadhyay et al., 2013). Because the IC3 domain is intact
in Gpr161vl, we hypothesized that Gpr161vl does not affect its
ciliary localization. To test this hypothesis we performed co-
immunostaining for Gpr161 and type III adenylyl cyclase (ACIII)
using differentiated neurons derived from adult subgranular zone
Fig. 2. Modvl5MOLF congenic rescues Gpr161vl NTD phenotypes. (A–L) Whole mount images of E11.5 embryos at low (A, D, G, J) and high (B, E, H, K) magniﬁcations (10 low;
25 high) along with Nissl stained transverse sections at posterior hindlimb axial level are shown (C, F, I, L). Normal (A–C) as well as mild (D–F), moderate (G–I) and severe
(J–L) NTDs are depicted. (M) The number (percentage shown in parentheses) of embryos with the above phenotypes is shown for Gpr161þ /vl Modvl5C/C x Gpr161þ /vl Modvl5C/
M and Gpr161þ /vl Modvl5C/M x Gpr161þ /vl Modvl5M/M matings. (N) The severity and incidence of Gpr161vl NTDs were assessed. Comparisons were made between the two
genotypes indicated on the left. Fisher's Exact test was used to assess the signiﬁcance of NTD incidence. Cochran–Mantel–Haenszel test based on rank scores was used to
determine the effect on NTD severity. P values are shown on the right two columns and signiﬁcant values (po0.05) are highlighted in red. Scale¼1 mm.
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(SGZ) of Gpr161þ /þ Modvl5C/C and Gpr161vl/vl Modvl5C/C mice. A
total of 152 ciliated cells in the Gpr161þ /þ Modvl5C/C background
and 163 ciliated cells in the Gpr161vl/vl Modvl5C/C background were
inspected. For both cell populations, 85%–90% (132/152 and
144/163, respectively) of the cells display Gpr161 and ACIII
colocalization in primary cilia (Supplementary Fig. 2I–J), demon-
strating that Gpr161vl mutation does not affect the localization of
Gpr161 to the cilia and suggests that the causes of Gpr161vl-
associated NTDs may be independent of the primary cilia.
Cdx1 contributes to Modvl5 QTL
Given Modvl5MOLF rescues the Gpr161vl-associated NTD pheno-
types and this is not caused by a signiﬁcant alteration of the Shh
pathway, our next goal was to identify cell biological pathways
that contribute to the rescue of the Gpr161vl NTDs. To accomplish
this we decided to take advantage of the genetic variation between
C3H and MOLF backgrounds in the Modvl5MOLF 95%CI. Our goal
was to identify at least one candidate quantitative trait gene (QTG)
that could contribute to the Gpr161vl NTD modifying effect, and to
use this QTG as an entry point to understand the cell biological
mechanism by which Gpr161vl/vl affects neurulation and how it is
rescued by the Modvl5MOLF congenic.
Because previously published data points to the Gpr161vl allele
affecting neural fold apposition and fusion, we started with the
simple model thatModvl5MOLF QTGs function cell autonomously so
we expected candidate genes to be expressed in the neural folds.
In addition since the Modvl5MOLF congenic does not rescue the
Gpr161vl cataract phenotype, candidate QTGs were expected not to
be expressed in the developing lens. To identify these candidate
genes we developed a bioinformatics pipeline using available
online genomic and expression data (http://compgen4.rutgers.
edu/devQTL/). A total of 123 genes are within Modvl5 95% CI.
Based on NCBI EST data, 63 of these genes are expressed at E8.5. By
mining the Bgee database, six of these 63 genes are co-expressed
with Gpr161 in the neural plate or neural ectoderm during Theiler
stages (TS) 11–16. Among these six genes, caudal type homeobox
transcription factor 1 (Cdx1) is the only gene that is co-expressed
with Gpr161 in the lateral neural folds during apposition and
fusion and is not expressed in the developing eye (Ikeya and
Takada, 2001; Matteson et al., 2008; Pilon et al., 2007), making it
the best candidate for the Modvl5 modifying effect on NTDs (for
lists of these genes, refer to Supplementary information).
If Cdx1 contributes to the Modvl5MOLF modifying effect, we
would expect either Cdx1 expression levels during neurulation to
be altered between Gpr161vl/vl Modvl5C/C and Gpr161vl/vl Modvl5C/M,
or at least one protein coding polymorphism to exist between C3H
and MOLF that affects the activity of the Cdx1 protein. We ﬁrst
measured Cdx1 mRNA levels at E8.5 and no difference was
observed between Gpr161þ /þ Modvl5C/C, Gpr161vl/vl Modvl5C/C
and Gpr161vl/vl Modvl5C/M (Fig. 4A). Next the Cdx1 protein coding
region was resequenced and an unannotated non-synonymous
polymorphism was identiﬁed in MOLF that inserts two additional
glutamines (Q) to a poly-Q stretch (C3H-5Qs; MOLF-7Qs) (Fig. 3A
and B).
The poly-Q is situated between two functional domains - the
DNA-binding homeodomain and a C-terminal protein-protein
interaction domain (Fig. 3C). The Cdx1 C-terminal domain regu-
lates binding speciﬁcity to its cofactors, which affects transcrip-
tional transactivation (Calon et al., 2007). Poly-Q tracts in other
transcription factors also affect DNA binding, transactivation and
protein-protein interaction (Chamberlain et al., 1994; Stott et al.,
1995; Wang et al., 2003), suggesting the Cdx1 poly-Q polymorph-
ism could have functional consequences. Consistent with this
possibility the Robson-Garnier algorithm predicts that the
Cdx1MOLF-7Q allele adds an additional B-‘turn’ between two
β-sheets (Fig. 3D). To further explore this possibility, a three-
dimensional protein model of Cdx1 was generated. The model
suggests that the two additional glutamines in Cdx1MOLF-7Q change
the distance and the orientation of C-terminal domain relative to
the homeodomain. For the Cdx1MOLF-7Q allele, the linker region is
longer and presents the protein interaction domain in a 2001
rotated orientation relative to the Cdx1C3H-5Q allele (Fig. 3E).
To directly test whether Cdx1 poly-Q polymorphism is func-
tional, an electrophoretic mobility shift assay (EMSA) was per-
formed on a validated consensus site (Gautier-Stein et al., 2003).
Nuclear extract containing either the Cdx1C3H-5Q or Cdx1MOLF-7Q
protein was mixed with double stranded biotinylated probes
encompassing the binding motif. A 40% increase of binding
intensity was observed for Cdx1MOLF-7Q compared to Cdx1C3H-5Q
(po0.01) (Supplementary Fig. 3A and B). Cold-competitor and
antibody supershift analysis demonstrated binding speciﬁcity
(Supplementary Fig. 3D). Western analysis determined no differ-
ence in Cdx1C3H-5Q and Cdx1MOLF-7Q protein levels (Supplementary
Fig. 3C).
Modvl5MOLF bypasses Gpr161vl-associated NTDs by regulating the
retinoic acid (RA) and canonical Wnt signaling pathways
Given Cdx1 is expressed in the neural folds and Cdx1MOLF
contains a functional polymorphism, we used Cdx1 as an entry
point to identify the developmental pathways by which Mod-
vl5MOLF rescues the Gpr161vl-associated NTDs. We ﬁrst investig-
ated whether Modvl5MOLF directly affects Gpr161 levels at E8.5.
A 60% decrease is observed in Gpr161vl/vl Modvl5C/C compared to
Gpr161þ /þ Modvl5C/C, but this is not rescued in Gpr161vl/vl
Modvl5C/M (Fig. 4B). Alternatively Modvl5MOLF could differentially
regulate downstream pathways, which compensates for the
Gpr161vl mutation. We examined the published literature and 28
candidate genes were identiﬁed that are expressed during neur-
ulation and their expression is affected by the family of Cdx
proteins (Chawengsaksophak et al., 2004; Prinos et al., 2001;
Savory et al., 2009, 2011; Sturgeon et al., 2011). Interestingly,
when the 10 kb upstream and downstream as well as intronic
regions of those genes were searched by online transcription
factor binding sites prediction software (http://www.cbrc.jp/
research/db/TFSEARCH.html), all 28 genes have at least one pre-
dicted Cdx binding site within those regions. These genes were
further narrowed down by three criteria: 1) whether mutations in
the gene cause NTDs in the mouse; 2) whether the gene is
expressed in the neural plate, and 3) whether the gene has a
validated Cdx binding site characterized by EMSA or luciferase
cotransfection assays. Only 4 genes fulﬁlled all three criteria:
Wnt3a, Cyp26a1, Ptk7 and Pax3 (Sanchez-Ferras et al., 2012;
Savory et al., 2009, 2011; Wagner et al., 2000; Yoshikawa et al.,
1997) (Supplementary Table 4).
Wnt3a is a ligand for canonical Wnt-signaling pathway
(Smolich et al., 1993); Cyp26a1 is a metabolic enzyme that
degrades all-trans retinoic acid (RA) (Abu-Abed et al., 2001);
Ptk7 is a tyrosine kinase receptor that genetically interacts with
non-canonical Wnt/PCP signaling (Lu et al., 2004) and Pax3 is a
paired box transcription factor that regulates several developmen-
tal pathways including Wnt and TGF-β signaling (Mayanil et al.,
2006; Sanchez-Ferras et al., 2012). All these signaling pathways
regulate neurulation (Lian et al., 2003; Muroyama et al., 2002;
Niederreither et al., 2002; Paudyal et al., 2010). We hypothesized
that Modvl5MOLF could bypass the Gpr161vl defects by regulating
these pathways.
To begin testing this possibility, qRT-PCR was conducted on
E8.5 embryos. For Wnt3a and Cyp26a1, diminished expression is
observed for Gpr161vl/vl Modvl5C/C compared to Gpr161þ /þ
Modvl5C/C. In Gpr161vl/vl Modvl5C/M expression of both genes is
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restored to wild type levels (Fig. 4C). Consistent with these results
EMSA analysis demonstrates that Cdx1MOLF protein binds with 30–
50% greater afﬁnity to three different validated Cdx1 binding sites
in the promoter region of Wnt3a and Cyp26a1 (Fig. 3F–H and
Supplemental Fig. 3E–G). For Ptk7 and Pax3, no signiﬁcant differ-
ence in mRNA levels is seen among the three genotypes (Fig. 4C).
Although this result does not rule out the possibility that Ptk7 and
Pax3 is involved in regulating Gpr161vl-associated NTDs, we
decided to further investigate canonical Wnt and RA signaling
within the scope of this paper.
To further investigate if the canonical Wnt and RA signaling are
downstream pathways regulated by Gpr161 and Cdx1, we tested the
expression of additional regulators of these two pathways at E8.5. For
Wnt signaling, in addition to the extracellular ligand Wnt3a, we tested
Axin2, which is a TCF/LEF transcription target that regulates the
degradation of beta-catenin (Jho et al., 2002), as well as a nuclear
protein Tcf7, which regulates the transcription of canonical Wnt target
genes (Roose et al., 1999). Axin2 showed a signiﬁcant decrease in
expression in Gpr161vl/vl Modvl5C/C embryos, with full restoration of
expression observed in Gpr161vl/vl Modvl5C/M. Tcf7 expression showed a
similar signiﬁcant decrease in Gpr161vl/vl Modvl5C/C embryos, and this
was partially rescued in Gpr161vl/vl Modvl5C/M but did not reach
signiﬁcance (Fig. 4D).
For RA signaling, we looked into RA metabolism pathways and
selected three additional enzymes that directly regulate the
synthesis and degradation of all-trans retinoic acid: Cyp26b1 and
Cyp26c1, which coregulate the degradation of RA with Cyp26a1,
and Aldh1a2, which is the major catalytic enzyme for the synthesis
of RA from retinaldehyde (Kam et al., 2012). For Aldh1a2, the
expression patterns among the 3 genotypes were similar to
Cyp26a1, in which lower expression is observed in Gpr161vl/vl
Modvl5C/C but is rescued in Gpr161vl/vl Modvl5C/M. However, for
Cyp26b1 and Cyp26c1, no expression level difference is observed
among the three genotypes (Fig. 4D). In summary, these results
identiﬁed Wnt3a, Tcf7, Axin2, Aldh1a2 and Cyp26a1 as canonical
Wnt and RA regulators that are disrupted by the Gpr161vl mutation
and rescued by the Modvl5MOLFcongenic.
To investigate potential differences in spatially-restricted expres-
sion of canonical Wnt and RA regulators, in situ hybridization (ISH)
and immunohistochemistry (IHC) was conducted at E8.5. At this age
the RA enzymes Cyp26a1 and Aldh1a2 are localized to different
regions of the embryo. Cyp26a1, the degradation enzyme, is localized
Fig. 3. Cdx1 poly-glutamine polymorphism. (A) A 6 bp insertion (red) for MOLF/Ei was identiﬁed, which results in the addition of (B) two glutamines (red) to a poly-glutamine
stretch (C3H-5Q; MOLF-7Q). (C) The poly-Q is predicted to serve as a linker between the homeodomain and C-terminal protein-protein interaction domain. (D) Robson-
Garnier protein secondary structure algorithm predicts an additional turn between two ß-sheets for the 7Q allele. (E) Protein modeling indicates that the two additional
glutamines (yellow) change the orientation of C-terminal domain (dashed arrow) relative to the homeodomain (green). (F) Schematic illustration of validated Cdx binding
sites in theWnt3a and Cyp26a1 promoters, as well as the predicted Cdx binding site in the Aldh1a2 promoter. (G) EMSAs validate the binding of Cdx1 to four binding sites in
the Wnt3a, Cyp26a1 and Aldh1a2 promoters. For Wnt3a and Cyp26a1 sites, previous analysis determined the linear range for the loading amount of nuclear extract in our
assay to be between 250 ng/ul and 125 ng/ul. For Aldh1a2, the linear range is determined to be between 650 ng/ul and 500 ng/ul. Nuclear extract was titrated to different
concentrations as labeled on top of each lane and the binding afﬁnity for Cdx1C3H and Cdx1MOLF to each site is shown. (H) Quantiﬁcation of Cdx1 binding afﬁnity in (G) (*:
Po0.05; **: Po0.01; student t test; two tailed, unpaired). Number of replicates: 3. Abbreviations: C: Myc-Cdx1C3H; M: Myc-Cdx1MOLF.
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to the posterior neural plate in the tail bud region (Fig. 5A). No
expression difference for Cyp26a1 is seen between the genotypes,
suggesting that the reduced qRTPCR levels are due to decreased
expression in the appropriate cell types (Fig. 5A–C). Aldh1a2 is
abundantly expressed in anterior regions including the somites and
closed neural tube (Fig. 5D). In E8.5 Gpr161vl/vl Modvl5C/C embryos,
the Aldh1a2 expression is broadly reduced in the closed neural tube
(Fig. 5e3, e3', f3 and f3'). In addition, the neural expression domain of
Aldh1a2 is shifted anteriorly (red arrows in Fig. 5e2/f2, comparing to
Fig. 5d2), and the posterior neural tube is open (red arrowheads in
Fig. 5e4/f4). For one Gpr161vl/vl Modvl5C/C embryo, in addition to the
reduction of Aldh1a2 expression in the neural tube, we also observed
a weaker expression in the somites, where RA is synthesized at this
stage (red arrows in Fig. 5f3/f4). Interestingly, all these phenotypes
are rescued in Gpr161vl/vl Modvl5C/M embryos (Fig. 5G).
For the canonical Wnt pathway we ﬁrst examined Wnt3a
expression by ISH. At E8.5 Wnt3a is expressed in the neural plate,
neural tube and tail bud. Consistent with the qRT-PCR result,
Gpr161vl/vl Modvl5C/C show reduced expression in all of the above
structures, which is restored in the Gpr161vl/vl Modvl5C/M (Fig. 6A–
C). Finally, IHC tested the expression of tyrosine phosphorylated
beta-catenin (PY489-beta catenin), a marker of canonical Wnt
signaling. The number of cells with positive staining, as well as the
average staining intensity per cell are both reduced in the
Gpr161vl/vl neural folds, and are rescued by the Modvl5MOLF con-
genic (Fig. 6D–G). These results provide additional support that
the Gpr161vl mutation affects the RA and canonical Wnt pathways
during neurulation and these phenotypes are rescued by the
Modvl5MOLF congenic.
To further investigate the connection between Modvl5MOLF and
Aldh1a2 in regulating RA signaling, we tested whether Cdx1 poly-
Q polymorphism would affect the binding to consensus sequences
in Aldh1a2 promoter. As no published literatures has validated any
Cdx binding sites in Aldh1a2, we searched the Aldh1a2 promoter
sequence by transcription factor binding prediction software
(TFsearch) and discovered only one predicted site within the
1 kb region upstream of the transcription starting site (Fig. 3F).
EMSA analysis demonstrates that Cdx1MOLF protein binds with
50% greater afﬁnity to this sequence, compared to the Cdx1C3H
protein (Fig. 3G–H). As Cdx1MOLF also binds to Cyp26a1 promoter
region with stronger afﬁnity, these results suggest that Cdx1
inﬂuences RA production by the transcriptional regulation of
multiple RA metabolism enzymes.
Because Aldh1a2 and Cyp26a1 act antagonistically to regulate
RA synthesis, we directly measured RA signaling by performing a
RARE-lacZ cell line coculturing assay (Kelley et al., 1993; Moise
et al., 2005; Wagner et al., 1992). This cell line is stably transfected
with a RA Response Element (RARE) that drives the expression of a
LacZ reporter. Dissociated embryos derived from E8.5 littermates
of Gpr161þ /þ Modvl5C/C, Gpr161vl/vl Modvl5C/C and Gpr161vl/vl
Modvl5C/M were cocultured with the reporter cell line for 24 h
and then quantitative colorimetric assays were performed. In
Gpr161vl/vl Modvl5C/C, a reduction in color intensity is observed
compared to Gpr161þ /þ Modvl5C/C, which was completely rescued
in Gpr161þ /þ Modvl5C/M (Fig. 7A,B). This result indicates that
downregulating Aldh1a2 and Cyp26a1 expression by the Gpr161vl
mutation leads to decreased RA production which is rescued by
the Modvl5MOLF congenic, suggesting RA synthesis is more impor-
tant than RA degradation to regulate neurulation in the Gpr161vl
mutant and the Modvl5MOLF background.
RA injection rescues the Gpr161vl NTD phenotypes
If decreased RA levels negatively affect neurulation in Gpr161vl,
elevating RA levels could mimic the effect of Modvl5MOLF and rescue
the NTDs. To test this possibility, Gpr161þ /vl x Gpr161þ /vlmatings were
conducted and intraperitoneal injection of 5 mg per kg of body weight
of all-trans RAwas performed. Vehicle injectionwas used as a negative
control. As an internal positive control and to test whether RA diffuses
into the embryo, Cyp26a1 expression was measured by qRTPCR.
Fig. 4. Gpr161vl affects mRNA levels of RA and canonical Wnt genes during neurulation and Modvl5MOLF rescues the defects. (A–D) E8.5 qRT-PCR demonstrated that Cdx1 mRNA
levels (A) are unaffected in Gpr161vl/vl Modvl5C/C and Gpr161vl/vl Modvl5C/M embryos while Gpr161 levels (B) are reduced in Gpr161vl/vl Modvl5C/C and are not rescued by the
Modvl5MOLF congenic. (C) Wnt3a and Cyp26a1 levels are decreased in Gpr161vl/vl Modvl5C/C and are rescued by the Modvl5MOLF congenic. Ptk7 and Pax3 levels are unaffected.
(D) Additional RA and canonical Wnt genes, Aldh1a2, Tcf7 and Axin2 are similarly decreased in Gpr161vl/vl Modvl5C/C and rescued by the Modvl5MOLF congenic. Cyp26b1 and
Cyp26c1 levels are unaffected. (*: Po0.05; **: Po0.01; ***: Po0.001; student t test; two tailed, unpaired). Number of replicates: 6–8 embryos per marker per genotype.
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Fig. 5. Gpr161vl affects spatial expression of RA gene, Aldh1a2, during neurulation and Modvl5MOLF restores normal expression. Whole mounts ISHs of E8.5 embryos along with
transverse sections at different axial levels are shown for Gpr161þ /þ Modvl5C/C, Gpr161vl/vl Modvl5C/C, Gpr161vl/vl Modvl5C/M. (A–C) Cyp26a1 expression is unaffected in all
embryos. (D–G) Aldh1a2 ISH images. Whole mount in situ at low (panel 1) and high (panel 10) magniﬁcations, with the magniﬁed images showing the expression pattern
between the 3rd and the 5th somites (panel 2). Transverse sections are shown at the 3rd (panel 3) and 6th somites (panel 4), with the magniﬁed images of the black boxed
area in panel 3 (panel 30). The axial levels for panel 3 and 4 are also indicated by black lines in panel 10 . In Gpr161vl/vl Modvl5C/C, Aldh1a2 displays reduced expression in the
neural tube (comparing e3/e30/f3/f30 to d3/d30/g3/g30) and an anterior shift in neural tube expression (e10 and f10 , also shown by red arrows in magniﬁed images in e2 and
f2). The posterior neural tube is open in Gpr161vl/vl Modvl5C/C (red arrowheads in e4 and f4, comparing to d4 and g4). One Gpr161vl/vl Modvl5C/C embryo also displays reduced
somatic expression of Aldh1a2 (f1 and f10, also shown by red arrows in f3 and f4). All these defects are not present in wildtype background (D) and are rescued by the
Modvl5MOLF congenic (G). Number of replicates: 3–5 embryos per marker per genotype. Scale¼50 um.
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Fig. 6. Gpr161vl affects spatial expression ofWnt3a and phosphorylated beta-catenin during neurulation and Modvl5MOLF rescues phenotype. (A–C) E8.5 ISH determined that
Wnt3a neural plate, neural tube and tail bud expression is reduced in Gpr161vl/vl Modvl5C/C and rescued in Modvl5MOLF congenic. The changes of Wnt3a expression in the
dorsal portion of neural tube are denoted by red arrowheads in a1-c1. (D–G) Neural fold canonical Wnt signaling as determined by IHC for phosphorylated β-catenin is
decreased in Gpr161vl/vlModvl5C/C and rescued by theModvl5MOLF congenic. (d1, e1 and f1) images taken from inverted microscope show the transverse section of E8.5 neural
fold (40X). Boxed area denotes the left and right lateral neural folds. (d2, d3, e2, e3, f2 and f3) high resolution (60X) images of the lateral neural folds are taken from confocal
laser scanning microscopy. Each image represents one depth of a set of Z-stack images. (G) ImageJ quantiﬁed the number of positive cells and average pixel intensity in the
boxed area. Number of replicates: 3–5 embryos per marker per genotype. (**: Po0.01; ***: Po0.001; student t test; two tailed, unpaired). Scale¼50 um.
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RA is known to up-regulate Cyp26a1 expression during neural tube
development (Dobbs-McAuliffe et al., 2004; Iulianella et al., 1999) and
as expected Cyp26a1 levels are increased in both Gpr161þ /þþRA and
Gpr161vl/vlþRA treated embryos (Fig. 7D), demonstrating the success-
ful diffusion of RA into the embryos.
Embryos were then dissected at E11.5 and Gpr161vl NTD
phenotypes were evaluated by using the same method described
previously. Consistent with our Modvl5MOLF analysis, 7 out of 20
Gpr161vl/vl embryos (35%) from the RA injection group display
normal neural tubes that are indistinguishable from Gpr161þ /þ
littermates, whereas for the vehicle injection group (N¼20),
almost all Gpr161vl/vl embryos but 1 display NTDs with different
severities (Fig. 7C). Fisher's exact test determined that RA injection
is sufﬁcient to rescue the incidence of Gpr161vl NTDs (po0.05).
Fig. 7. RA signaling is downstream of Gpr161 during neurulation. (A) F9 RARE-lacZ reporter cells were cultured for 24 h. Cells were then stained with X-gal and colorimetric
assay was performed. Representative images are shown. (B) Relative RA intensity of individual embryos for Gpr161þ /þ Modvl5C/C (round points), Gpr161vl/vl Modvl5C/C (square
points) or Gpr161vl/vl Modvl5C/M (diamond points) is shown. Each data point represents a single embryo. Average RA intensities of each genotype are shown as dashed lines
and error bars are shown as solid lines. (C) All-trans RA was intraperitoneally injected, and the number (percentage) of E11.5 embryos with different severities of NTDs was
compared between RA-injected and vehicle-injected groups. Comparisons on NTD incidence and severity were made using the same statistical methods as described in
Fig. 2. RA injection suppresses the incidence but not the severity of Gpr161vl/vl Modvl5C/C NTDs. (D–F) QRT-PCR analysis demonstrates that RA injection up-regulates canonical
Wnt marker expression (F). (D) Cyp26a1 is up-regulated by RA as previously reported and RA injection caused a slightly decreased Gpr161 expression for both Gpr161þ /þ
Modvl5C/C and Gpr161vl/vl Modvl5C/C (E). Number of replicates for qRT-PCR: N¼7 per marker per genotype (*: Po0.05; **: Po0.01; ***: Po0.001; student t test; two tailed,
unpaired).
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In contrast, when NTD severity was evaluated using the Cochran-
Mantel-Haenszel test described previously, RA injection group
shows no difference to vehicle (p¼0.4805). These results indicate
that elevating in vivo RA levels partially recapitulates the modify-
ing effect of Modvl5MOLF during neurulation, suggesting that there
are parallel pathways other than RA that rescues the NTD severity
in the congenics.
To investigate if NTD rescue was correlated with increased
Gpr161 levels, qRTPCR was performed at E11.5. RA treatment
slightly decreased levels of Gpr161 in both Gpr161þ /þ and
Gpr161vl/vl, indicating that the rescue is not due to a restoration
of Gpr161 levels (Fig. 7E).
Next, we investigated the response of canonical Wnt pathway
to RA injection. A previous study has shown that RA functions
upstream of the canonical Wnt pathway during neurulation
(Martinez-Morales et al., 2011). Consistent with this report, RA
treatment is sufﬁcient to elevate the expression ofWnt3a, Tcf7 and
Axin2 in both E11.5 Gpr161þ /þ and Gpr161vl/vl embryos. Interest-
ingly, the expression level for all three genes in the Gpr161vl/vlþRA
embryos increased beyond vehicle Gpr161þ /þ levels and is com-
parable to the Gpr161þ /þþRA levels (Fig. 7F) and is correlated
with the RA rescue of Gpr161vl NTDs. These results indicate that
canonical Wnt may be downstream of RA signaling to regulate
Gpr161vl NTDs.
Discussion
Gpr161vl does not signiﬁcantly affect the Shh pathway and primary
cilia localization
A previous report indicates that Gpr161 functions in primary
cilia and affects Shh signaling during neurulation. In this published
study the Gpr161 null allele results in fully penetrant lethality,
craniorachischisis and severe craniofacial abnormalities. These
defects are due to the up-regulation of the Shh pathway and
ventralization of neural tube patterning (Mukhopadhyay et al.,
2013). These phenotypes are also commonly observed in other
primary cilia mutants.
In this study, we showed that the Gpr161vl hypomorphic allele,
unlike the null allele, only minimally affects Shh signaling. QRT-PCR
and ISH demonstrate that the levels and spatial-temporal expres-
sion of Ptch1, Gli1 and Gli3 are only mildly affected in Gpr161vl/vl. In
addition, theModvl5MOLF congenic has little effect on the expression
of Shh signaling factors, suggesting that the Modvl5MOLF congenic
rescues the Gpr161vl/vl NTD phenotypes by a different pathway.
Consistent with this conclusion, co-immunostaining Gpr161 with
the primary cilia marker ACIII in differentiated neurons demon-
strates that Gpr161vl does not affect its localization to primary cilia,
indicating that the mutation may speciﬁcally affect the non-ciliary
functions of Gpr161. Gpr161vl/vl embryos also display less severe
phenotypes than the null. Instead of severe craniofacial defects,
exencephaly and craniorachischisis reported in the null allele
analysis, Gpr161vl/vl embryos display NTDs that are almost univer-
sally restricted to the developing spinal cord, which include spina
biﬁda and dorsal neuroepithelial phenotypes. In addition while
embryonic lethality is fully penetrant in the Gpr161 null allele,
approximately two-thirds of the Gpr161vl/vl embryos survive into
adulthood.
Previous histological, ultra-structural and in vitro explant
analyses suggest that the Gpr161vl allele affects the last step in
neurulation, apposition and fusion of the neural folds. Together
these data support the model that the Gpr161vl allele bypasses
most of the effects of the Shh pathway during early neurulation
and allows the investigation of Gpr161 function during later stages
of neurulation. However these pathways are unknown, and in this
paper we have used natural variation in the mouse to identify
these pathways.
Modvl5MOLF rescue of Gpr161vl NTDs
Our analysis demonstrates that the Modvl5MOLF is sufﬁcient to
rescue the embryonic lethality and partially repress the incidence
and severity of NTDs. Although embryonic lethality in Gpr161vl/vl
Modvl5C/C coincides with neural fold apposition and fusion, it is
unlikely that NTDs are the cause of lethality in Gpr161vl. This is due
to three reasons: one, in other mouse NTD mutant models (e.g.
Crooked tail, Splotch, etc), lethality is often caused by pre-
implantational defect or cardiovascular defect that happens before
or after the neurulation (Conway et al., 1997; Gray et al., 2010).
Two, at E8.5–E9.5, defective yolk sac function or connection of
allantois to chorion in forming the chorio-allantoic placenta has
been shown to be the major contributing factor of lethality (Moser
et al., 2004; Stumpo et al., 2004); Three, although RA injection
represses the incidence of Gpr161vl-associated NTDs, it has no
effect on the lethality (data not shown). Therefore, other uniden-
tiﬁed abnormalities during or prior to E8.5-E9.5 may be the cause
of embryonic lethality in Gpr161vl.
Human NTD is a multifactorial disorder. However, most pre-
vious mouse NTD research has focused on single mutations, which
do not recapitulate the multifactorial basis of the human disorder
(Harris and Juriloff, 2007, 2010). Our previous report on Gpr161vl
demonstrated that natural variations in different inbred strains
affect the incidence and severity of NTDs, establishing Gpr161vl as
a valuable system to study the multigenic regulation of NTDs
(Matteson et al., 2008). In this study, we complement previous
ﬁndings by presenting Modvl5MOLF as a QTL that rescues Gpr161vl-
associated NTDs. Interestingly, the modifying effect of Modvl5 is
partial with two thirds of the Gpr161vl/vl Modvl5C/M embryos still
display abnormal NTD phenotypes, suggesting that other uniden-
tiﬁed genetic variants that map outside ofModvl5 could contribute
to additional NTD rescue.
Determination of QTL candidate genes is difﬁcult due to the
large number of genes and polymorphisms in the 95% CI. In this
study, we used a novel approach by building a high-throughput
bioinformatics platform to retrieve developmental gene expres-
sion data from NCBI EST and Bgee databases. While it remains
possible that other genes within the 95% CI are expressed in
developmentally relevant structures and also contribute to the
rescue of Gpr161vl-associated NTDs, four pieces of data support
Cdx1 as a QTG for Modvl5MOLF. One, Cdx1 is expressed with Gpr161
in the neural folds. Two, the poly-glutamine polymorphism is
predicted to affect secondary and tertiary protein structure. Three,
EMSAs demonstrated that the Cdx1MOLF-7Q allele binds with
greater afﬁnity to four Cdx1 binding sites including consensus
sequences for biologically relevant RA and Wnt pathway genes.
Four, other studies have demonstrated that Cdx1 interacts with
Wnt and RA signaling to regulate neurulation (Houle et al., 2000;
Pilon et al., 2007). These data fulﬁll the criteria established by the
Complex Trait Consortium and other groups that have identiﬁed
QTGs and QTNs (Abiola et al., 2003; Cohen-Zinder et al., 2005;
Milner and Buck, 2010). Identifying Cdx1 as a possible QTG
provided an entry point to study the cell biological mechanism
of Gpr161vl associated NTDs.
RA and canonical Wnt pathways are downstream of Gpr161 during
neurulation
RA signaling is known to regulate neurulation and neural crest
development. Elevating or reducing RA causes NTDs, with
increased RA causing a delay in posterior neural pore closure
(Kapron-Bras and Trasler, 1988), and premature neural crest
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migration (Martinez-Morales et al., 2011). RA ablation causes
abnormal neural tube development with a wider ﬂoor plate, a
thicker roof plate and an altered dorsoventral shape (Wilson et al.,
2003). Our qRT-PCR, ISH, F9-RARE-LacZ coculturing assay, and RA
injection data demonstrates a causative relationship between
Gpr161 and RA signaling and supports the Gpr161 regulating
neurulation via RA.
E8.5 qRT-PCR demonstrates that Aldh1a2, which synthesizes
RA, and Cyp26a1, which degrades RA, are both reduced in Gpr161vl/
vl Modvl5C/C. However, our ISH results show that in Gpr161vl/vl
Modvl5C/C, Aldh1a2 expression is reduced in the somites as well as
in the neural tube whereas no alteration of Cyp26a1 expression is
detected. To directly test how RA levels are affected in vivo, we
performed F9-RARE-LacZ/E8.5 embryonic co-culture experiments
as well as intraperitoneal RA injection analysis. Our co-culture
assay demonstrated a reduction in RA signaling in Gpr161vl/vl
Modvl5C/C, which is further supported by the RA injections, which
suppress the incidence of NTDs. These results suggest that RA
synthesis is more important than RA degradation to regulate
neurulation in the Gpr161vl mutant background.
Disruption of canonical Wnt signaling has been shown to
impair neurulation (Allache et al., 2014; Nagai et al., 2000;
Takada et al., 1994). Our results indicate decreased canonical
Wnt signaling activity in Gpr161vl/vl, with Wnt3a, Tcf7 and Axin2
mRNA levels being downregulated as well as diminished neural
fold expression of Wnt3a and tyrosine-phosphorylated beta-cate-
nin. These results place canonical Wnt as one of the downstream
signaling pathways of Gpr161 during neurulation.
In addition, RA has been shown to function upstream of the
canonical Wnt pathway during neural fold development
(Martinez-Morales et al., 2011). Our results support this previous
ﬁnding by showing that RA injection is sufﬁcient to rescue the
Wnt3a, Tcf7 and Axin2 expression level defect in Gpr161vl/vl
embryos.
Interestingly, Modvl5MOLF rescue of Gpr161vl NTDs is associated
with a corresponding restoration of the RA and canonical Wnt
pathways. qRT-PCR, ISH and F9-RARE-LacZ coculturing assays all
indicate that RA expression and signaling are rescued in Gpr161vl/vl
Modvl5C/M embryos. Similar results are observed for Wnt markers
and phosphorylated beta-catenin. Since Gpr161 levels are not
rescued by Modvl5MOLF, these results suggest that Modvl5MOLF is
a bypass allele that rescues NTDs by restoring the activity of
downstream targets of Gpr161, RA and canonical Wnt signaling
(Fig. 8 and Supplementary Fig. 1D).
One question not resolved in this study is how cell biologically
Gpr161 is linked to RA signaling during neurulation. The recent
study on Gpr161 null allele demonstrates that Gpr161 is upstream
of Gs-cAMP-PKA signaling cascade (Mukhopadhyay et al., 2013).
Two previous publications indicate that PKA phosphorylates the
RA-receptor subunit alpha (RARA) at Serine 77 and Serine 369,
which in turn affect the nuclear localization and DNA binding
afﬁnity of the receptor (Gaillard et al., 2006; Santos and Kim,
2010). Therefore, it's possible that in Gpr161vl, PKA activity as well
as the RARA function is disrupted, leading to the downregulation
of RA signaling and RA target genes.
As the study on Gpr161 null allele convincingly showed that
Gpr161 functions through primary cilia, we wonder how this
reconciles with the function of RA during neurulation. We propose
two models: 1) Primary cilia are implicated in establishing the
unidirectional ﬂuid ﬂow in the node, setting up the left-right
asymmetry and resulting in the release of RA (Sirbu and Duester,
2006; Yoshiba et al., 2012). A zebraﬁsh study demonstrated that
Gpr161 is also necessary to establish left-right asymmetry during
gastrulation (Leung et al., 2008). It's possible that the Gpr161vl
allele impairs the release of RA from the node, which in turn
diminishes RA signaling throughout the embryo before neurula-
tion. Reduced RA levels could then later affect neural fold apposi-
tion and fusion in a cilia-independent manner. 2) Alternatively RA
may regulate other signaling pathways (not Shh as it is not
severely affected in Gpr161vl) in primary cilia. The other pathway
known to function in primary cilia is PDGFRa (Schneider et al.,
2005). PDGFRa regulates cytoskeletal changes, cell migration and
apoptosis, all of which are needed during neural fold apposition
and fusion (Pickett et al., 2008). RA directly regulates PDGFRa
receptor expression so increases in RA by theModvl5MOLF congenic
or RA injection could result in increased PDGFRa expression and
signaling via the primary cilia (Liebeskind et al., 2000). Our
preliminary analysis indicates PDGFRa mRNA level is not signiﬁ-
cantly altered by the Gpr161vl mutation or the Modvl5MOLF con-
genic background during neurulation (Supplemental Fig. 4A).
However, intraperitoneal injection of RA to pregnant female is
sufﬁcient to upregulate the PDGFRa level in the embryos (Supple-
mental Fig. 4B). Interestingly, this effect can only be observed in
the Gpr161vl/vl background as no difference in PDGFRa level is seen
between Gpr161þ /þþvehicle and Gpr161þ /þþRA embryos. We
hypothesize that in parallel to the canonical Wnt signaling, RA
may function through PDGFRa signaling in the primary cilia to
rescue Gpr161vl/vl–associated NTDs.
In summary, by taking advantage of natural variation in the
mouse we have identiﬁed Modvl5MOLF as a functional QTL that
rescues embryonic lethality and NTDs in Gpr161vl. Bioinformatics
and molecular analyses identiﬁed Cdx1 as one QTG for Modvl5MOLF.
Fig. 8. Gpr161 Modvl5MOLF model. Our results support Gpr161 being upstream of RA which then activates the canonical Wnt pathway during neurulation. In Gpr161vl/vl
Modlv5C/C, RA and canonical Wnt signaling are down-regulated (dashed arrows), contributing to NTDs. In Gpr161vl/vl Modvl5C/M the Gpr161vl mutation is bypassed by the
restored RA and Wnt signaling, which then partially rescues the NTDs. Cdx1MOLF is one QTG in Modvl5, which contributes to the Modvl5MOLF rescuing effects.
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Using Cdx1 as an entry point, we discovered that the RA and
canonical Wnt pathways function downstream of Gpr161 during
neurulation. These studies further establish Gpr161vl as a multigenic
mouse model for NTDs and provide new insight into the molecular
and cellular pathways regulated by Gpr161 during neurulation.
Material and methods
Modvl5MOLF congenic generation
All mice are maintained on a 12:12 light/dark cycle as approved
by the Rutgers-RWJMS IACUC. To generate the Modvl5MOLF con-
genics, the C3H/HeSnJ and MOLF/EiJ inbred mice were inter-
crossed to generate F1 hybrids. C3H/MOLF hybrid mice were
then backcrossed to isogenic C3H mice for 8–10 generations. For
each generation, genome-wide genotyping was performed by
using 65 evenly distributed Simple Sequence Length Polymorph-
ism (SSLP) markers (Whitehead Institute, MIT) that are poly-
morphic between C3H and MOLF. The male mice with the most
contribution to the C3H background but were still C3H/MOLF for
theModvl5 QTL 95% CI (determined by D18MIT50) were selected to
generate the next generation (Supplementary Fig. 1A). After
Modvl5C/M congenics were generated, they were crossed to each
other to generate Modvl5M/M. Modvl5M/M congenics were then
crossed to Gpr161þ /vl isogenic C3H mice to generate Gpr161þ /vl
Modvl5C/M. To study whether homozygous congenics have addi-
tional modifying effects, the Gpr161þ /vl Modvl5C/M x Modvl5M/M
mating was performed to generate Gpr161þ /vl Modvl5M/M mice
(Supplemental Fig. 1B and C).
Modvl5MOLF congenic analysis
Littermates derived from the matings Gpr161þ /vl Modvl5C/C x
Gpr161þ /vl Modvl5C/M and Gpr161þ /vl Modvl5C/M x Gpr161þ /vl
Modvl5M/M (Supplementary Fig. 1C) were used for morphological
and molecular analysis. For adult analysis, tail samples of post-
weaning adult were collected and processed with Wizard SV
genomic DNA puriﬁcation kit (Promega). The DNA samples were
then genotyped for Gpr161 and Modvl5 95% CI (PCR condition:
94 1C 15 s, 51 1C 15 s, 72 1C 45 s-30 cycles). For Gpr161vl mutation,
a primer pair ﬂanking the 8- bp deletion as described in (Matteson
et al., 2008) was used. For Modvl5, 6 SSLP MIT markers that are
evenly distributed within the Modvl5 17 Mb interval (from prox-
imal to distal: D18MIT181, D18MIT140, D18MIT40, D18MIT184,
D18MIT50, D18MIT141) were genotyped (for primer sequences,
refer to genome.ucsc.edu). For embryonic analysis, copulation
plugs were identiﬁed at 12PM, which was deﬁned as E0.5. At
E8.5, E9.5 or E11.5, females were sacriﬁced by cervical dislocation
and embryos were dissected and separated from the yolk sac. Yolk
sac genomic DNA was puriﬁed by treating with GoTaqs Flexi
Buffer (Promega), Proteinase K and SDS at 55 1C for 1 h.
Determination of embryonic lethality
To determine the incidence of Gpr161vl-associated embryonic
lethality on the C3H isogenic background, we counted the number
of viable adult Gpr161vl/vl Modvl5C/C mice derived from three
different matings: 1) isogenic C3H Gpr161þ /vl x Gpr161þ /vl, 2)
Gpr161þ /vl Modvl5C/C x Gpr161þ /vl Modvl5C/M and 3) Gpr161þ /vl
Modvl4C/C x Gpr161þ /vl Modvl4C/M. Isogenic Gpr161vl/vl C3H adult
mice were identiﬁed by PCR for relevant C3H/MOLF genomic
markers and the Gpr161vl mutation. If no lethality occurs we
expect 25% of the progeny to be Gpr161vl/vl in the cross 1 while
12.5% will have the Gpr161vl/vl Modvl5C/C genotype in crosses 2 and
3. Totally 642 adult mice were generated from the three matings
(126 from mating 1; 229 from mating 2 and 287 from mating 3). If
no lethality is occurred, we expect the number of Gpr161vl/vl
Modvl5C/C mice to be 96 (126*25%þ229*12.5%þ287*12.5%¼96).
However, 62 Gpr161vl/vl Modvl5C/C mice were observed, sugges-
ting the incidence of lethality in isogenic C3H background to be
1–62/96¼36%.
Histological analysis
To analyze the NTD phenotypes, the Gpr161þ /vl Modvl5C/M x
Gpr161þ /vl Modvl5C/C and Gpr161þ /vl Modvl5C/M x Gpr161þ /vl
Modvl5M/M matings were performed. E11.5 embryos were har-
vested and ﬁxed overnight with Bouin's Solution. Whole mount
embryos were inspected under the stereomicroscope and pictures
at low and high magniﬁcation of the posterior neural tube were
taken. Transverse parafﬁn sections were then generated and
processed for Nissl staining. The incidence and severity of NTDs
for each genotype group was quantiﬁed and statistically analyzed
by Fisher's Exact and Cochran-Mantel-Haenszel tests.
Bioinformatics analysis
An in-house bioinformatics pipeline was used to identify candi-
date genes within Modvl5. Computer scripts were written to mine
the NCBI Entrez Gene and Expressed Sequence Tag (EST) databases
(Unigene: Build 181). The list of genes that overlap or are within the
95% conﬁdence interval of Modvl5 (Chr18: 54842801-71874635) was
obtained (see Supplementary information for the list of gene names).
The Bgee database (http://bgee.unil.ch/bgee/bgee) contains expres-
sion data for 20,421 mouse genes, all 40 developmental stages, and
6,048 anatomical structures. These data were analyzed to obtain the
list of genes co-expressed with Gpr161 in the neural ectoderm during
neural tube development (Theiler stage 11–16) and also in the
developing eye (Theiler stage 16–23).
Homology modeling of Cdx1
A three-dimensional model of Cdx1 was constructed using
ModBase (Pieper et al., 2011). This was aligned with the HoxA9-
DNA structure (LaRonde-LeBlanc and Wolberger, 2003) using
pyMol (www.pymol.org). Idealized poly-glutamine a-helices with
5 or 7 repeats were constructed in pyMol and grafted on the C-
terminus of the Cdx1 structure.
Molecular analysis
Details of cloning, EMSA, Western blotting, immunostaining,
qRT-PCR and ISH studies are provided in Supplementary
information.
RARE-reporter cell line assay
The F9-RARE-lacZ reporter cell line was maintained as
described (Wagner et al., 1992) and seeded 100,000 cells/well.
After 24 h, E8.5 embryos were dissected, dissociated in 0.25%
Trypsin-EDTA for 5 min at 37 1C and the cell suspension was
placed on top of the reporter cells. No embryonic tissue and
1 nM at-RA were used as negative and positive controls. The tissue
lysate and the cells were cocultured for 24 h at 37 1C, ﬁxed in 2.5%
glutaraldehyde, then standard X-gal washing and staining proto-
cols were followed (Wagner et al., 1992). The color on each plate
was quantiﬁed at 610 nM by ELISA reader. Quantities for each well
was subtracted to negative control and then normalized to the
average value of all wells on the same plate.
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RA injection analysis
40 mg/ml all-trans RA (Sigma) was stored and diluted as
described (Chen et al., 1994). Pregnant females received a single
intraperitoneal RA (5 mg/kg of body weight) or vehicle injection at
E9.5. E11.5 embryos were dissected and processed with morpho-
logical and histological analysis as described.
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